Company Filing History:
1 out of 832,912 Years Active: 2011
Title: Innovations by Silke Muller
Introduction
Silke Muller is an accomplished inventor based in Schonborn, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of immunomodulating compositions. Her work focuses on the interaction between fetal hemoglobin and bacterial endotoxin, leading to novel therapeutic applications.
Latest Patents
Silke Muller holds a patent for her invention titled "Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components." This patent describes a pharmaceutical composition that exhibits a unique immunomodulating principle. The invention reveals that the combination of bacterial endotoxin and fetal hemoglobin, particularly its heme-free derivative, demonstrates a pronounced synergistic biomedical activity. This activity is not merely based on the classical function of hemoglobin as an oxygen transporter but rather on the modulation of endotoxin-mediated bioactivity. The composition can be administered orally and has potential applications in treating allergic conditions, malignancies, chronic infections, autoimmune phenomena, and age-related imbalances.
Career Highlights
Throughout her career, Silke Muller has focused on innovative approaches to enhance immune system responses. Her research has led to groundbreaking discoveries that have the potential to transform therapeutic strategies in various medical fields.
Collaborations
Silke Muller has collaborated with notable individuals in her field, including Otto Westphal and Josette Westphal, who serves as her legal representative. These collaborations have contributed to the advancement of her research and the successful development of her patented compositions.
Conclusion
Silke Muller is a pioneering inventor whose work in immunomodulating compositions has opened new avenues for medical treatment. Her innovative approach to combining fetal hemoglobin and bacterial endotoxin showcases the potential for significant advancements in therapeutic applications.